A detailed history of Beirne Wealth Consulting Services, LLC transactions in Amgen Inc stock. As of the latest transaction made, Beirne Wealth Consulting Services, LLC holds 2,772 shares of AMGN stock, worth $863,367. This represents 0.33% of its overall portfolio holdings.

Number of Shares
2,772
Previous 2,941 5.75%
Holding current value
$863,367
Previous $847 Million 6.96%
% of portfolio
0.33%
Previous 0.42%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $45,439 - $54,850
-169 Reduced 5.75%
2,772 $788 Million
Q4 2023

Feb 06, 2024

BUY
$255.7 - $288.46 $15,853 - $17,884
62 Added 2.15%
2,941 $847 Million
Q1 2023

May 10, 2023

SELL
$225.79 - $275.2 $13,773 - $16,787
-61 Reduced 2.07%
2,879 $696 Million
Q4 2021

Feb 03, 2022

SELL
$198.88 - $227.6 $4,972 - $5,690
-25 Reduced 0.84%
2,940 $661,000
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $15,311 - $17,843
-69 Reduced 2.27%
2,965 $738,000
Q4 2020

Feb 03, 2021

SELL
$216.38 - $257.67 $23,585 - $28,086
-109 Reduced 3.47%
3,034 $698,000
Q3 2020

Nov 05, 2020

BUY
$234.65 - $260.95 $24,403 - $27,138
104 Added 3.42%
3,143 $799,000
Q2 2020

Jul 31, 2020

SELL
$197.81 - $242.74 $217,195 - $266,528
-1,098 Reduced 26.54%
3,039 $717,000
Q1 2020

Apr 28, 2020

SELL
$182.24 - $241.7 $305,434 - $405,089
-1,676 Reduced 28.83%
4,137 $839,000
Q4 2019

Jan 14, 2020

BUY
$189.21 - $243.2 $481,917 - $619,430
2,547 Added 77.99%
5,813 $1.4 Million
Q2 2019

Jul 25, 2019

SELL
$166.7 - $195.41 $18,503 - $21,690
-111 Reduced 3.29%
3,266 $602,000
Q1 2019

May 14, 2019

BUY
$180.87 - $203.88 $361 - $407
2 Added 0.06%
3,377 $642,000
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $602,100 - $702,843
3,375 New
3,375 $657,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Beirne Wealth Consulting Services, LLC Portfolio

Follow Beirne Wealth Consulting Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beirne Wealth Consulting Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beirne Wealth Consulting Services, LLC with notifications on news.